Key Takeaways
- In 2022, South Korea's total health expenditure reached 12.5% of GDP, equivalent to USD 67.8 billion, with public spending comprising 52.3% of total health expenditure.
- Life expectancy at birth in South Korea was 83.6 years in 2022, highest in OECD.
- In 2023, South Korea had 4.2 hospital beds per 1,000 population, exceeding the OECD average of 4.1.
- South Korea's pharmaceutical market size was USD 22.5 billion in 2022, growing 4.8% YoY.
- National Health Insurance drug price reductions averaged 15.2% for 1,200 items in 2023.
- South Korea had 2.6 physicians per 1,000 population in 2022, below OECD average but with high productivity.
South Korea’s healthcare industry shows strong demand, with rising investment and continued growth across key segments.
Related reading
01 · Category
Expenditure16 stats
Expenditure Interpretation
02 · Category
Health Outcomes17 stats
Health Outcomes Interpretation
03 · Category
Infrastructure19 stats
Infrastructure Interpretation
More related reading
04 · Category
Pharmaceuticals17 stats
Pharmaceuticals Interpretation
05 · Category
Policy15 stats
Policy Interpretation
06 · Category
Workforce19 stats
Workforce Interpretation
Cite This Report
This report is designed to be cited. We maintain stable URLs and versioned verification dates. Copy the format appropriate for your publication below.
Marcus Afolabi. (2026, February 13). South Korea Healthcare Industry Statistics. Gitnux. https://gitnux.org/south-korea-healthcare-industry-statistics
Marcus Afolabi. "South Korea Healthcare Industry Statistics." Gitnux, 13 Feb 2026, https://gitnux.org/south-korea-healthcare-industry-statistics.
Marcus Afolabi. 2026. "South Korea Healthcare Industry Statistics." Gitnux. https://gitnux.org/south-korea-healthcare-industry-statistics.
Sources & references
13 datasets cited across this report · attribution is report-level

